Major Depressive Disorder chronic | Recurrent major depressive episodes Quantity
Item
chronic mdd according to dsm-iv (modification: depressive symptomatology for at least one year), or recurrent mde (third or greater episode with the immediately preceding episode being no more than 2.5 years before the onset of the present episode)
boolean
C1269683 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0154409 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Age
Item
age 18-65
boolean
C0001779 (UMLS CUI [1])
Montgomery-Asberg Depression Rating Scale Questionnaire
Item
score of at least 18 on the montgomery-asberg-rating scale for depression (madrs)
boolean
C4054475 (UMLS CUI [1])
At risk for suicide
Item
acute risk for suicide
boolean
C0563664 (UMLS CUI [1])
Psychotic symptom | Bipolar Disorder | Dementia
Item
history of psychotic symptoms, bipolar disorder or dementia
boolean
C0871189 (UMLS CUI [1])
C0005586 (UMLS CUI [2])
C0497327 (UMLS CUI [3])
Substance Use Disorders Severe | Substance Dependence Severe
Item
severe substance-related abuse or dependence disorder
boolean
C0038586 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0038580 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Schizotypal Personality Disorder | Antisocial Personality Disorder | Borderline Personality Disorder
Item
schizotypal, antisocial or borderline personality disorder
boolean
C0036363 (UMLS CUI [1])
C0003431 (UMLS CUI [2])
C0006012 (UMLS CUI [3])
Medical condition Serious
Item
serious medical condition
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Severe cognitive impairment
Item
severe cognitive impairment
boolean
C3554639 (UMLS CUI [1])
Investigational New Drugs Unresponsive to Treatment | Other Coding
Item
absence of a response to previous adequate trial of the study medication/cbasp
boolean
C0013230 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
Hypersensitivity Escitalopram
Item
hypersensitivity to escitalopram
boolean
C0020517 (UMLS CUI [1,1])
C1099456 (UMLS CUI [1,2])
Monoamine Oxidase Inhibitors
Item
treatment with a mao-inhibitor within 1 week before the initiation of study treatment
boolean
C0026457 (UMLS CUI [1])